Validation of the ALBI-TAE model and comparison of seven scoring systems for predicting survival outcome in patients with intermediate‐stage hepatocellular carcinoma undergoing chemoembolization

BACKGROUND: The ALBI-TAE model was recently proposed as a scoring system to select suitable patients with intermediate-stage hepatocellular carcinoma (HCC) for transarterial chemoembolization (TACE). However, this scoring system has not been externally validated. Therefore, we validated this score a...

Descripción completa

Detalles Bibliográficos
Autores principales: Bannangkoon, Kittipitch, Hongsakul, Keerati, Tubtawee, Teeravut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228079/
https://www.ncbi.nlm.nih.gov/pubmed/37248526
http://dx.doi.org/10.1186/s40644-023-00575-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228079/
https://www.ncbi.nlm.nih.gov/pubmed/37248526
http://dx.doi.org/10.1186/s40644-023-00575-6

Ejemplares similares